QH

Qiyue Hu

JC Jiangsu Hengrui Medicine Co.: 5 patents #3 of 80Top 4%
SC Shanghai Hengrui Pharmaceutical Co.: 5 patents #3 of 60Top 5%
📍 Shanghai, CA: #78 of 451 inventorsTop 20%
Overall (2022): #28,179 of 548,613Top 6%
5
Patents 2022

Issued Patents 2022

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
11535633 Fused tricyclic heterocycle compounds and therapeutic uses thereof Dong Liu, Lei Chen, Linghang Zhuang, Puhui Li, Xinzhu Zhang +5 more 2022-12-27
11525005 Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof Shude Yan, Jiahua Jiang, Lianshan Zhang, Guoqing CAO, Xueming Qian +1 more 2022-12-13
11512129 TIGIT antibody, antigen-binding fragment thereof, and medical use thereof Yayuan FU, Zhuoxiao CAO, Weikang Tao 2022-11-29
11365247 IL-5 antibody, antigen binding fragment thereof, and medical application therefor Hua Ying, Jinping Shi, Yifang Wang, Hu Ge, Weikang Tao 2022-06-21
11359021 PD-L1 antibody, antigen-binding fragment thereof, and pharmaceutical use thereof Xiaoling Gu, Jiahua Jiang, Lei Zhang, Jinming Gu, Weikang Tao 2022-06-14